JP6426746B2 - ４−メチルスルホニル−２−ブテンニトリル及びその医薬上の使用 - Google Patents

４−メチルスルホニル−２−ブテンニトリル及びその医薬上の使用 Download PDF

Info

Publication number
JP6426746B2
JP6426746B2 JP2016546873A JP2016546873A JP6426746B2 JP 6426746 B2 JP6426746 B2 JP 6426746B2 JP 2016546873 A JP2016546873 A JP 2016546873A JP 2016546873 A JP2016546873 A JP 2016546873A JP 6426746 B2 JP6426746 B2 JP 6426746B2
Authority
JP
Japan
Prior art keywords
pain
pharmaceutical composition
inflammation
butenenitrile
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016546873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539179A (ja
JP2016539179A5 (https=
Inventor
ピー．セント ローレント ジョーセフ
ピー．セント ローレント ジョーセフ
エス．ジョーンズ ジェラルド
エス．ジョーンズ ジェラルド
エム．ブレス デイビッド
エム．ブレス デイビッド
エー．グッドリッチ スコット
エー．グッドリッチ スコット
Original Assignee
オラテック セラピューティクス リミティド ライアビリティ カンパニー
オラテック セラピューティクス リミティド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オラテック セラピューティクス リミティド ライアビリティ カンパニー, オラテック セラピューティクス リミティド ライアビリティ カンパニー filed Critical オラテック セラピューティクス リミティド ライアビリティ カンパニー
Publication of JP2016539179A publication Critical patent/JP2016539179A/ja
Publication of JP2016539179A5 publication Critical patent/JP2016539179A5/ja
Application granted granted Critical
Publication of JP6426746B2 publication Critical patent/JP6426746B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2016546873A 2013-10-07 2014-10-01 ４−メチルスルホニル−２−ブテンニトリル及びその医薬上の使用 Active JP6426746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887776P 2013-10-07 2013-10-07
US61/887,776 2013-10-07
PCT/US2014/058685 WO2015054008A1 (en) 2013-10-07 2014-10-01 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use

Publications (3)

Publication Number Publication Date
JP2016539179A JP2016539179A (ja) 2016-12-15
JP2016539179A5 JP2016539179A5 (https=) 2017-10-26
JP6426746B2 true JP6426746B2 (ja) 2018-11-21

Family

ID=52813515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016546873A Active JP6426746B2 (ja) 2013-10-07 2014-10-01 ４−メチルスルホニル−２−ブテンニトリル及びその医薬上の使用

Country Status (4)

Country Link
EP (1) EP3055286A4 (https=)
JP (1) JP6426746B2 (https=)
CN (1) CN105683158A (https=)
WO (1) WO2015054008A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015094626A1 (en) * 2013-12-20 2015-06-25 The Procter & Gamble Company Diaper with improved cuffs and comfort

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444175A (en) * 1966-11-09 1969-05-13 Merck & Co Inc Certain picolylmethyl sulfones
EP2651407B1 (en) * 2010-12-15 2016-12-21 Olatec Industries LLC 3-methanesulfonylpropionitrile for treating inflammation and pain
JP6151723B2 (ja) * 2012-02-27 2017-06-21 オラテック セラピューティクス リミティド ライアビリティ カンパニー ３−メチルスルホニルプロピオニトリルを調製するプロセス
WO2014043144A1 (en) * 2012-09-11 2014-03-20 Olatec Industries Llc Methods for treating inflammation and pain

Also Published As

Publication number Publication date
JP2016539179A (ja) 2016-12-15
EP3055286A4 (en) 2017-05-24
EP3055286A1 (en) 2016-08-17
WO2015054008A1 (en) 2015-04-16
CN105683158A (zh) 2016-06-15

Similar Documents

Publication Publication Date Title
US20230372279A1 (en) Pharmaceutical composition for treating inflammation and pain
US20180303787A1 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
JP6426746B2 (ja) ４−メチルスルホニル−２−ブテンニトリル及びその医薬上の使用
JP6360163B2 (ja) ３，４−ビス−ベンジルスルホニルブタンニトリル及びその医薬上の使用
US9750714B2 (en) Pharmaceutical use of 3, 4-bis-benzylsulfonylbutyronitrile
WO2013188214A1 (en) Compounds for treating inflammation and pain
US9770429B2 (en) 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use
AU2014308958B9 (en) Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate
CN104394860B (zh) 用于治疗炎症和疼痛的化合物
JP6457502B2 (ja) ３−ベンジルスルホニルプロピオニトリルの医薬上の使用
CN105682460B (zh) 3,4-双-苄磺酰基丁腈及其药学用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170915

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180515

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180731

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180925

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181025

R150 Certificate of patent or registration of utility model

Ref document number: 6426746

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250